Table 1 Prevalence and comorbidities of the sample (N = 273)
| Â | MDD | GAD | SBD | PD | SAD | Agoraphobia | PTSD | OCD |
|---|---|---|---|---|---|---|---|---|
| Â | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
Total prevalence | 127 (46.52) | 137 (50.18) | 11 (4.06) | 53 (19.41) | 40 (14.71) | 48 (17.58) | 57 (20.88) | 87 (31.87) |
Women | 100 (79.4) | 110 (80.3) | 8 (72.7) | 44 (83.0) | 28 (70.0) | 40 (83.3) | 47 (82.5) | 62 (71.3) |
Men | 27 (21.3) | 27 (19.7) | 3 (27.3) | 9 (17.0) | 12 (30.0) | 6 (12.5) | 10 (17.5) | 25 (28.7) |
Mean Age (SD) | 44.02 (14.76) | 41.54 (14.66) | 44.64 (11.42) | 39.87 (14.43) | 37.88 (12.35) | 43.88 (13.60) | 40.11 (13.77) | 39.35 (13.47) |
Comorbidities | Â | Â | Â | Â | Â | Â | Â | Â |
MDD | - | 81 (59.12) | 5 (45.45) | 26 (49.05) | 22 (55.00) | 26 (54.16) | 32 (56.14) | 45 (51.72) |
GAD | 81 (63.77) | - | 6 (54.54) | 38 (71.69) | 27 (67.50) | 35 (72.91) | 42 (73.18) | 60 (68.96) |
SBD | 5 (3.93) | 6 (4.37) | - | 4 (7.54) | 3 (8.5) | 6 (12.50) | 5 (8.77) | 8 (9.19) |
PD | 26 (20.47) | 38 (27.73) | 4 (36.36) | - | 14 (35.00) | 23 (47.91) | 17 (29.82) | 27 (31.03) |
SAD | 22 (17.32) | 27 (19.70) | 3 (27.27) | 14 (26.41) | - | 26 (54.16) | 19 (33.33) | 21 (24.13) |
Agoraphobia | 26 (20.47) | 35 (25.54) | 6 (54.54) | 23 (43.39) | 26 (65.00) | - | 22 (38.59) | 24 (27.58) |
PTSD | 32 (25.19) | 42 (30.65) | 5 (45.45) | 17 (32.07) | 19 (47.50) | 22 (45.83) | - | 29 (33.33) |
OCD | 45 (35.43) | 60 (43.79) | 8 (72.72) | 27 (50.94) | 21 (52.50) | 24 (50.00) | 29 (50.87) | - |